BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 29024949)

  • 41. The long-term effects of early oral feeding following minimal invasive esophagectomy.
    Berkelmans GHK; Fransen L; Weijs TJ; Lubbers M; Nieuwenhuijzen GAP; Ruurda JP; Kouwenhoven EA; van Det MJ; Rosman C; van Hillegersberg R; Luyer MDP
    Dis Esophagus; 2018 Jan; 31(1):1-8. PubMed ID: 29025081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal surgical approach for esophageal cancer in the era of minimally invasive esophagectomy and neoadjuvant therapy.
    Noordman BJ; Wijnhoven BP; van Lanschot JJ
    Dis Esophagus; 2016 Oct; 29(7):773-779. PubMed ID: 26382935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study.
    Hauser C; Patett C; von Schoenfels W; Heits N; Schafmayer C; Malchow B; Hampe J; Schniewind B; Becker T; Egberts JH
    Dis Esophagus; 2015 Oct; 28(7):652-9. PubMed ID: 25059631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy.
    Kelley ST; Coppola D; Karl RC
    J Gastrointest Surg; 2004; 8(3):227-31; discussion 231-2. PubMed ID: 15019913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.
    Qin Q; Xu H; Liu J; Zhang C; Xu L; Di X; Zhang X; Sun X
    Int J Surg; 2018 Nov; 59():11-18. PubMed ID: 30261331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
    Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
    BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012.
    Sabra MJ; Smotherman C; Kraemer DF; Nussbaum MS; Tepas JJ; Awad ZT
    J Surg Oncol; 2017 Mar; 115(3):296-300. PubMed ID: 27813095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study.
    Siddiqui AA; Loren D; Dudnick R; Kowalski T
    Dig Dis Sci; 2007 Mar; 52(3):823-9. PubMed ID: 17253137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Six weeks of home enteral nutrition versus standard care after esophagectomy or total gastrectomy for cancer: study protocol for a randomized controlled trial.
    Bowrey DJ; Baker M; Halliday V; Thomas AL; Pulikottil-Jacob R; Smith K
    Trials; 2014 May; 15():187. PubMed ID: 24885032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer.
    Martin RC; Cannon RM; Brown RE; Ellis SF; Williams S; Scoggins CR; Abbas AE
    Oncologist; 2014 Mar; 19(3):259-65. PubMed ID: 24567281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
    Woodard GA; Crockard JC; Clary-Macy C; Zoon-Besselink CT; Jones K; Korn WM; Ko AH; Gottschalk AR; Rogers SJ; Jablons DM
    J Surg Oncol; 2016 Dec; 114(7):838-847. PubMed ID: 27569043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer.
    Hamai Y; Hihara J; Emi M; Murakami Y; Kenjo M; Nagata Y; Okada M
    Ann Thorac Surg; 2015 Jun; 99(6):1887-93. PubMed ID: 25912745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laparoscopic feeding jejunostomy in esophagogastric cancer.
    Jenkinson AD; Lim J; Agrawal N; Menzies D
    Surg Endosc; 2007 Feb; 21(2):299-302. PubMed ID: 17122985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study.
    Bowrey DJ; Baker M; Halliday V; Thomas AL; Pulikottil-Jacob R; Smith K; Morris T; Ring A
    Trials; 2015 Nov; 16():531. PubMed ID: 26590903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Meta-analysis of Jejunostomy Versus Nasoenteral Tube for Enteral Nutrition Following Esophagectomy.
    Li HN; Chen Y; Dai L; Wang YY; Chen MW; Mei LX
    J Surg Res; 2021 Aug; 264():553-561. PubMed ID: 33864963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity of upfront surgery for patients with unsuspected lymph node metastasis in esophageal cancer: a propensity scoring matching study.
    Park JK; Kim JJ; Moon SW; Cho DG
    J Cardiothorac Surg; 2018 Jun; 13(1):62. PubMed ID: 29880029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.
    Markar SR; Johar A; Maisey N; Lagergren P; Lagergren J
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29293984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.
    Low DE; Kunz S; Schembre D; Otero H; Malpass T; Hsi A; Song G; Hinke R; Kozarek RA
    J Gastrointest Surg; 2007 Nov; 11(11):1395-402; discussion 1402. PubMed ID: 17763917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.